DTU Logo
Publications | Conference abstracts | Slidesets | Webcasts

Publications (18 of 430)

Search Publications :


Fire-and-forget in prevention of coronary heart disease
Karpe F, Holman R.
Lancet 2002;360:1984. Published:14-Dec-2002. Epub:13-Dec-2002. PMID:12493308. doi:10.1016/S0140-6736(02)11890-3

Modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Stevens RJ, Stratton IM, Holman RR.
J Diabetes Complications 2002;16:371-376. Published:Nov-2002. Epub:04-Dec-2002. PMID:12477619. doi:10.1016/S1056-8727(02)00161-7

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling of 2143 patients with ruptured intracranial aneurysms: a randomised trial
Molyneux A, Kerr R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R
J Stroke Cerebrovasc Dis. 2002;11:304-14. Published:Nov-2002. doi:10.1053/jscd.2002.130390

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling of 2143 patients with ruptured intracranial aneurysms: a randomised trial
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Lancet 2002;360:1267-1274. Published:26-Oct-2002. PMID:12414200. doi:10.1016/S0140-6736(05)67214-5

The economics of translating trial evidence into practice: costs of implementing more intensive glycaemic and blood pressure control in type 2 diabetes in England
Gray A, Clarke P, Farmer A, Holman R for the United Kingdom Prospective Diabetes Study (UKPDS) Group
British Medical Journal 2002;325:1-6. Published:19-Oct-2002. PMID:12386035. doi:10.1136/bmj.325.7369.860

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
Viberti G. Kahn SE. Greene DA. Herman WH. Zinman B. Holman RR. Haffner SM. Levy D. Lachin JM. Berry RA. Heise MA. Jones NP. Freed MI.
Diabetes Care 2002;25:1737-1743. Published:Oct-2002. PMID:12351470. doi:10.2337/diacare.25.10.1737

Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated with Improved Outcomes?
Colagiuri S, Cull CA, Holman RR
Diabetes Care 2002;25:1410-1417. Published:Aug-2002. PMID:12145243. doi:10.2337/diacare.25.5.894

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D
Clarke P, Gray A, Holman R
Medical Decision Making 2002;4:340-349. Published:Aug-2002. PMID:12150599. doi:10.1177/0272989X0202200412

Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine
Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR
Stroke 2002;33:1776-1781. Published:Jul-2002. PMID:12105351. doi:10.1161/01.STR.0000020091.07144.C7

Prevention Conference VI: Diabetes and Cardiovascular Disease
Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL
Circulation 2002;105:e153. Published:07-May-2002. PMID:11994266. doi:10.1161/01.CIR.0000014022.85836.96

A non-invasive frequent home blood glucose monitor
Lenzen H, Barrow BA, White S, Holman RR.
Practical Diabetes 2002;19:101-103. Published:May-2002. Epub:28-May-2002. doi:10.1002/pdi.312

Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling
Herlihy OM, Barrow BA, Grant PJ, Levy JC
Diabetologia 2002;45:635-641. Published:May-2002. Epub:26-Apr-2002. PMID:12107743. doi:10.1007/s00125-002-0795-8

Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes.
Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR
Diabetes Care 2002;25:894-899. Published:May-2002. PMID:11978687. doi:10.2337/diacare.25.5.894

Human calcium/calmodulin-dependent protein kinase II gamma gene (CAMK2G): cloning, genomic structure and detection of variants in subjects with type II diabetes
Gloyn AL, Desai M, Clark A, Levy JC, Holman RR, Frayling TM, Hattersley AT, Ashcroft SJH
Diabetologia 2002;45:58-583. Published:Apr-2002. PMID:12032636. doi:10.1007/s00125-002-0779-8

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)
Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR.
Diabetes Care 2002;25:330-336. Published:Feb-2002. PMID:11815505. doi:10.2337/diacare.25.2.330
Erratum in :
Diabetes Care 2002;25:1268, Print:Jul-2002, doi:10.2337/diacare.25.7.1268

Standardization of glycated haemoglobin
Marshall SM, Home PD, Manley SM, Barth JH, John WG.
Annals of Clinical Biochemistry 2002;39:77-79. Published:Jan-2002. PMID:11853199

Analysis of the United Kingdom Prospective Diabetes Study
Holman RR
Endocrine Practice 2002;8 Supplement 1:33-34. Published:Jan-2002. doi:10.4158/EP.8.S1.33

Calculation of coronary risk in Type 2 diabetes: another cause for concern: authors' reply
Holman RR, Manley SE, Stevens RJ on behalf of the UKPDS Study Group
Clinical Science 2002;103:217-219. Published:01-Aug-2001. doi:10.1042/cs1030217v